Anti-PEG antibody for the quantification and targeting of PEGylated compounds and affinity-evolution by somatic hypermutaiton
博士 === 國立陽明大學 === 微生物及免疫學研究所 === 101 === PEGylation is a mature technology for modification of compounds to improve their pharmacokinetic index. To successfully launch the PEGylated compounds to the clinic, the development of accurate methods for the quantitative analysis of pharmacokinetic paramete...
Main Authors: | Yu-Cheng Su, 蘇昱誠 |
---|---|
Other Authors: | Steve Roffler |
Format: | Others |
Language: | en_US |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/03316727046853384847 |
Similar Items
-
Optimizations of Anti-PEG Sandwich ELISA for Quantification of PEGylated molecules
by: Ming-Yang Tzeng, et al.
Published: (2013) -
The role of somatic mutation in determining the affinity of anti-DNA antibodies.
by: Behrendt, M., et al.
Published: (2009) -
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
by: Wen-Wei Lin, et al.
Published: (2021-04-01) -
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
by: Hiroshi Kiwada, et al.
Published: (2010-12-01) -
Selective Delivery of PEGylated Compounds to Tumors by Bispecific Antibodies
by: HSIN-YI TUNG, et al.
Published: (2015)